Answers are grounded in this paper and cite their sources.
Retrospective cohort study reveals targeted pharmacological treatments significantly reduce mortality in hospitalized COVID-19 patients, highlighting the value of risk-stratified management.
INTRODUCTION: We conducted the present analysis to understand the clinical outcomes in patients with COVID-19 infection and the factors associated with mortality over the one-and-a-half years of the pandemic in Mumbai, India. METHODS: This is a retrospective cohort study of 3561 COVID-19 patients admitted to a private tertiary care hospital in Mumbai, India. The main outcome variable for analysis was death (yes/no). We compared the characteristics of COVID-19 patients who had died during their stay in the hospital with those who had not died. We used survival analysis to identify the factors associated with mortality. RESULTS: The mortality rate was 0.71 per 100 person-days (95% CI: 0.61-0.81 per 100 person days (PD)); it was higher (2.03 (95% CI: 1.47, 2.82) per 100 PD) in those aged >= 80 years compared with 18-39 years (p<0.001). The hazard rate (HR) was significantly higher in those with chronic liver disease (HR: 5.12, 95% CI: 1.78, 14.71; p=0.002) and lower in those who were treated with injection enoxaparin (HR: 0.46, 95% CI: 0.31, 0.69; p<0.001). In patients without breathing difficulties, the hazard was significantly lower in those treated with doxycycline (HR: 0.41, 95% CI: 0.17, 0.99; p=0.05). In patients who presented with breathing difficulties, hazard was significantly lower in those who were treated with remdesivir (HR: 0.52, 95% CI: 0.31, 0.90; p=0.019). In patients who required ventilatory support (invasive and non-invasive), the hazard was significantly lower with injected tocilizumab (HR: 0.56, 95% CI: 0.36, 0.89; p=0.013). CONCLUSIONS: The mortality was highest during the initial days of the pandemic and in patients with co-morbidities. Remdesivir and the tocilizumab injection were useful in the reduction of mortality in the severe form of COVID-19 infection. Doxycycline was useful in milder and less severe forms of infection. However, enoxaparin injection was associated with lower mortality in most of these cases.
No takes yet. Share an insight, caveat, or question.
Tulara et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: